| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSWI | Common Stock | Options Exercise | $0 | +12.5K | +25.01% | $0.00 | 62.5K | Apr 3, 2024 | Direct | |
| transaction | CSWI | Common Stock | Tax liability | -$1.14M | -4.92K | -7.87% | $231.92 | 57.6K | Apr 3, 2024 | Direct | |
| holding | CSWI | Common Stock | 1.5K | Apr 3, 2024 | JBA Family Partners, L.P. | ||||||
| holding | CSWI | Common Stock | 3.05K | Apr 3, 2024 | by ESOP |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSWI | Performance Rights | Options Exercise | $0 | -6.15K | -100% | $0.00* | 0 | Apr 3, 2024 | Common Stock | 6.15K | Direct | F1 | |
| holding | CSWI | Performance Rights | 7.85K | Apr 3, 2024 | Common Stock | 7.85K | Direct | F2 | ||||||
| holding | CSWI | Performance Rights | 12.4K | Apr 3, 2024 | Common Stock | 12.4K | Direct | F3 | ||||||
| holding | CSWI | Performance Rights | 27.6K | Apr 3, 2024 | Common Stock | 27.6K | Direct | F4 | ||||||
| holding | CSWI | Restricted Stock Units | 19.7K | Apr 3, 2024 | Common Stock | 19.7K | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 97 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. |
| F2 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |
| F3 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |
| F4 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles ending on each of March 31, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |
| F5 | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer. |